These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27832779)

  • 1. miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma.
    Ren K; Li T; Zhang W; Ren J; Li Z; Wu G
    J Biomed Sci; 2016 Nov; 23(1):79. PubMed ID: 27832779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma.
    Liu W; Zheng L; Zhang R; Hou P; Wang J; Wu L; Li J
    Mol Cancer; 2022 Mar; 21(1):72. PubMed ID: 35277182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-222-3p induced by hepatitis B virus promotes the proliferation and inhibits apoptosis in hepatocellular carcinoma by upregulating THBS1.
    Sun Y; Shi P; Wu Q; Liu B; Yu Z; Jia H; Chang H
    Hum Cell; 2021 Nov; 34(6):1788-1799. PubMed ID: 34273068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.
    Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD
    Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-424-5p Regulates Hepatoma Cell Proliferation and Apoptosis.
    Piao L; Wang F; Wang Y; Yang Z; Li Q; Cui L; Yu Q
    Cancer Biother Radiopharm; 2019 Apr; 34(3):196-202. PubMed ID: 30676784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines.
    Henry JC; Park JK; Jiang J; Kim JH; Nagorney DM; Roberts LR; Banerjee S; Schmittgen TD
    Biochem Biophys Res Commun; 2010 Dec; 403(1):120-5. PubMed ID: 21055388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.
    Lou G; Chen L; Xia C; Wang W; Qi J; Li A; Zhao L; Chen Z; Zheng M; Liu Y
    J Exp Clin Cancer Res; 2020 Jan; 39(1):4. PubMed ID: 31898515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silence of lncRNA HEIH suppressed liver cancer cell growth and metastasis through miR-199a-3p/mTOR axis.
    Ma Y; Cao D; Li G; Hu J; Liu X; Liu J
    J Cell Biochem; 2019 Oct; 120(10):17757-17766. PubMed ID: 31144384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
    Huang GH; Shan H; Li D; Zhou B; Pang PF
    Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-199a/b-3p inhibits HCC cell proliferation and invasion through a novel compensatory signaling pathway DJ-1\Ras\PI3K/AKT.
    Ma LN; Wu LN; Liu SW; Zhang X; Luo X; Nawaz S; Ma ZM; Ding XC
    Sci Rep; 2024 Jan; 14(1):224. PubMed ID: 38168113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
    Liu Z; Ouyang G; Lu W; Zhang H
    Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma.
    Wang XP; Yao J; Guan J; Zhou ZQ; Zhang ZY; Yang J
    Biomed Pharmacother; 2018 Mar; 99():817-824. PubMed ID: 29710480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L; Zhang Y
    Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis.
    Zhou Y; Li K; Zou X; Hua Z; Wang H; Bian W; Wang H; Chen F; Dai T
    Bioengineered; 2021 Dec; 12(2):10862-10877. PubMed ID: 34666613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
    Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
    Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1.
    Zhang H; Liu H; Bi H
    Oncol Rep; 2017 Aug; 38(2):843-849. PubMed ID: 28677785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.
    Jiang C; Long J; Liu B; Xu M; Wang W; Xie X; Wang X; Kuang M
    J Exp Clin Cancer Res; 2017 Jul; 36(1):99. PubMed ID: 28750679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
    Shi Y; Yan F; Wang F; Pan L
    Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.
    Tschaharganeh DF; Chen X; Latzko P; Malz M; Gaida MM; Felix K; Ladu S; Singer S; Pinna F; Gretz N; Sticht C; Tomasi ML; Delogu S; Evert M; Fan B; Ribback S; Jiang L; Brozzetti S; Bergmann F; Dombrowski F; Schirmacher P; Calvisi DF; Breuhahn K
    Gastroenterology; 2013 Jun; 144(7):1530-1542.e12. PubMed ID: 23419361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.